journal article·1983-01

Use of magnetic emulsion as a novel drug carrier for chemotherapeutic agents

M Akimoto, Y Morimoto

Biomaterials· Volume 4· Issue 1
Publisher page

Abstract

No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.

Source: Not provided · Quality: missing

Research context

OpenAlex topics: Amino Acid Enzymes and Metabolism · Digestive system and related health

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (14)

Show source-provided references
1. Drugcarrier potential of liposomes in cancer chemotherapy
2. Albumin microspheres as vehicles for achieving specificity in drug delivery10.1002/jps.2600631044 ↗
3. Drug-carrier property of albumin microspheres in chemotherapy. V. Antitumor effect of microsphere-entrapped adriamycin on liver metastasis of AH 7974 cells in rats10.1248/cpb.29.1433 ↗
4. Increased lymphatic delivery of bleomycin by microsphere in oil emulsion and its effect on lymph node metastasis10.1016/0378-5173(79)90031-0 ↗
5. Magnetic microsphere. A model system for site specific drug delivery in vivo
6. Biomedical application of magnetic fluids. I Magnetic idance of ferrocolloid-entrapped albumin microsphere for site specific drug delivery in vivo10.1248/bpb1978.3.264 ↗
7. Biomedical applications of magnetic fluids. II Preparation and magnetic guidance of magnetic albumin microsphere for site specific drug delivery in vivo10.1248/bpb1978.4.624 ↗
8. Biomedical applications of magnetic fluids III. Antitumor effect of magnetic albumin microsphere-entrapped adriamycin on lung metastasis of AH 7974 in rats10.1016/0142-9612(82)90009-6 ↗
9. Magnetically controlled metallic thrombosis of intracranial aneurysms
10. Stabilization of aqueous magnetic suspension. Preparation of waterbased magnetic fluid10.1246/nikkashi.1976.6 ↗
11. Colormetric method for the determination of 1,3-bis(2-chloroethyl)-1-nitrosourea10.1002/jps.2600540538 ↗
12. Methyl-CCNU in clinical cancer therapy10.1016/S0305-7372(74)80018-6 ↗
13. 2-chloroethanol formation as evidence for a 2-chloroethyl alkylating intermediate during chemical degradation of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea and 1-(2-chloroethyl)-3-(frans-4-methyl-cyclohexyl)-1-nitrosourea
14. Study of methyl-CCNU in the treatment of lung cancer